Results 271 to 280 of about 740,500 (344)

Underexplored moderating effects of sex in subjective cognitive decline: A systematic review and evidence gap. [PDF]

J Alzheimers Dis
Álvarez-Pérez Y, Duarte-Díaz A, Molina Y, Figueroa-Lamas N, Diaz-Galvan P, García-Cabello E, Gonzalez-Burgos L, Yánes-Pérez R, Rivero-Santana A, Olofsson JK, Barroso J, Ferreira D, Perestelo-Pérez L, Cedres N.   +13 more
europepmc   +1 more source

Inter-Local Coherence: A Methodological Framework for the Structural Compatibility of Independent Observational Sequences

Nekludoff, Alexey A.
openalex   +1 more source

Effectiveness and Safety of Nusinersen and Risdiplam in Spinal Muscular Atrophy: A Systematic Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Spinal Muscular Atrophy (SMA) is a rare genetic disorder marked by progressive muscle weakness and mobility loss. It has a profound physical, emotional and social impact on patients and caregivers, requiring comprehensive medical and supportive care.
Amin Mehrabian, Peter Auguste, Amy Grove, Anna Brown, Janette Parr, Mubarak Patel, Furqan Butt, Jeremiah Donoghue, Mehdi Yousefi, Jo Parsons   +9 more
wiley   +1 more source

Disposition and effects of alpha-pyrrolidinoisohexanophenone (α-PHiP) in comparison with cocaine: an observational study. [PDF]

Front Pharmacol
De la Rosa G, Iacobone G, Papaseit E, Hladun O, Poyatos L, Caicedo DA, Argote MC, Martín S, Ventura M, Di Giorgi A, Graziano S, Pichini S, Marchei E, Farré M, Pérez-Mañá C.   +14 more
europepmc   +1 more source

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin, Liu Dong, Ying Wang, Dingxian He, Chong Yan, Jianying Xi, Haoqin Jiang, Yu Shi, Ming Guan, Chongbo Zhao, Jie Song, Sushan Luo   +11 more
wiley   +1 more source

Lower versus standard dose-intensity continuous renal replacement therapy: a protocol for a systematic review and meta-analysis. [PDF]

BMJ Open
Lumlertgul N, Kusirisin P, Kung JY, Duquette D, Fujii T, Zarbock A, Wald R, Bagshaw SM.   +7 more
europepmc   +1 more source

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein, Maximilian Mönch, Meret Herdick, Frauke Stascheit, Sarah Hoffmann, Hannah Preßler, Philipp Mergenthaler, Carla Dusemund, Paolo Doksani, Haoqi Sun, Pushpa Narayanaswami, Andreas Meisel, Lea Gerischer, Sophie Lehnerer   +13 more
wiley   +1 more source

Comparing survival with vitamin K antagonists, low-molecular-weight heparin, and direct oral anticoagulants in patients with cancer-a systematic review and meta-analysis. [PDF]

Res Pract Thromb Haemost
Xirou V, Patel A, Altamirano MFA, Singh R, Gusdorf J, Barnum K, McNichol M, Ryu J, Zwicker JI, Chiasakul T, Patell R.   +10 more
europepmc   +1 more source